Arcadia Biosciences, Inc. (RKDA) — Cost of Revenue
| Fiscal Year | Cost of Revenue | Change YoY |
|---|---|---|
| 2025 | $3.10M | +4.6% |
| 2024 | $2.96M | +36.3% |
| 2023 | $2.17M | -64.4% |
| 2022 | $6.10M | -29.9% |
| 2021 | $8.71M | +67.5% |
| 2020 | $5.20M | — |
| Fiscal Year | Cost of Revenue | Change YoY |
|---|---|---|
| 2025 | $3.10M | +4.6% |
| 2024 | $2.96M | +36.3% |
| 2023 | $2.17M | -64.4% |
| 2022 | $6.10M | -29.9% |
| 2021 | $8.71M | +67.5% |
| 2020 | $5.20M | — |